Skip to content

Clinical Evaluation of the Causes of Contact Lens Related Dry Eye

A Clinical Evaluation of the Causes of Soft Contact Lens Related Dry Eye

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00995189
Enrollment
159
Registered
2009-10-15
Start date
2009-08-31
Completion date
2010-04-30
Last updated
2016-11-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Contact Lens Related Dry Eye

Keywords

contact lens wear, multi-purpose solution, corneal staining

Brief summary

The purpose of this study was to clinically evaluate the potential causes of contact lens-related dry eye.

Detailed description

Daily wear soft contact lens wearers reporting significant contact lens-related dryness symptoms were enrolled. Late day dryness with contact lenses, intensity grade 3-5, frequency sometimes / frequently / constantly as evaluated by a questionnaire was considered significant.

Interventions

Contact lens care solution containing polyquaternium-1 (PQT)

Contact lens care solution containing polyhexamethylene biguanide (PHMB)

Daily wear, frequent replacement contact lenses per participant's habitual brand and power.

Sponsors

Alcon Research
Lead SponsorINDUSTRY

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Reports late-day dryness symptoms with contact lens wear on questionnaire. * Wears FDA Group 2 hydrogel, FDA Group 4 hydrogel, or silicone hydrogel lenses. * Consistently uses either polyhexamethylene biguanide (PHMB) or polyquaternium-1 (PQT) contact lens care products (i.e. \>6 months including 1 month immediately before enrollment). * Other protocol-defined inclusion criteria may apply.

Exclusion criteria

* Wears daily disposable contact lenses. * Has significant symptoms related to lens fit or lens deposits. * Requires concurrent ocular medication (rewetting drops allowed). * Has used Restasis® in the last 3 months. * Wears punctal plugs fitted in the last 30 days. * Has any current systemic or ocular abnormality, infection or disease. * Uses any current systemic medication likely to affect tear film, e.g. antihistamines, betaadrenergic blockers, steroids. * Has a history of refractive surgery. * Other protocol-defined

Design outcomes

Primary

MeasureTime frame
Subjective Dryness2 weeks, one month

Secondary

MeasureTime frame
corneal staining2 weeks, one month
conjunctival stainingtwo weeks, one month

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026